Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Tue, 09 Jun 2026 11:24:44 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngIn the starting blocks for heart preservation and PrimECC trialhttps://news.cision.com/xvivo-perfusion/r/in-the-starting-blocks-for-heart-preservation-and-primecc-trial,c3151914cision3715285Fri, 10 Jul 2020 05:30:00 GMTConference call on Interim Reporthttps://news.cision.com/xvivo-perfusion/r/conference-call-on-interim-report,c3146965cision3709344Thu, 02 Jul 2020 06:30:00 GMTThe study from Lund published in Nature Communicationshttps://news.cision.com/xvivo-perfusion/r/the-study-from-lund-published-in-nature-communications,c3133490cision3693466Fri, 12 Jun 2020 14:30:00 GMTRedeye: Xvivo Perfusion - Well-preserved valuehttps://news.cision.com/xvivo-perfusion/r/redeye-xvivo-perfusion--well-preserved-value,c3123369cision3679868Fri, 29 May 2020 13:53:38 GMTMagnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusionhttps://news.cision.com/xvivo-perfusion/r/magnus-nilsson-hands-over-the-baton-to-dag-andersson-as-president-and-ceo-of-xvivo-perfusion,c3099660cision3649728Tue, 28 Apr 2020 16:30:00 GMTStrong cash flow despite the influence of Covid-19https://news.cision.com/xvivo-perfusion/r/strong-cash-flow-despite-the-influence-of-covid-19,c3084661cision3628774Thu, 09 Apr 2020 05:30:00 GMTConference call on Interim Report (link updated)https://news.cision.com/xvivo-perfusion/r/conference-call-on-interim-report--link-updated-,c3082264cision3625353Mon, 06 Apr 2020 09:30:00 GMTReport from Annual general meeting of XVIVO Perfusion AB (publ)https://news.cision.com/xvivo-perfusion/r/report-from-annual-general-meeting-of-xvivo-perfusion-ab--publ-,c3078179cision3620272Tue, 31 Mar 2020 15:00:00 GMTXPS™ sold to pediatric transplantation clinic in Italyhttps://news.cision.com/xvivo-perfusion/r/xps--sold-to-pediatric-transplantation-clinic-in-italy,c3077512cision3619515Tue, 31 Mar 2020 07:30:00 GMTThe Nomination Committee proposes unchanged Board remuneration -adjusted versionhttps://news.cision.com/xvivo-perfusion/r/the-nomination-committee-proposes-unchanged-board-remuneration--adjusted-version,c3068162cision3608814Wed, 25 Mar 2020 09:50:00 GMTThe Nomination Committee proposes unchanged Board remunerationhttps://news.cision.com/xvivo-perfusion/r/the-nomination-committee-proposes-unchanged-board-remuneration,c3068104cision3608783Wed, 25 Mar 2020 09:15:00 GMTXVIVO Perfusion advances the date for submission of the January-March 2020 interim reporthttps://news.cision.com/xvivo-perfusion/r/xvivo-perfusion-advances-the-date-for-submission-of-the-january-march-2020-interim-report,c3067761cision3608562Wed, 25 Mar 2020 07:30:00 GMTAs a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are takenhttps://news.cision.com/xvivo-perfusion/r/as-a-result-of-covid-19--the-annual-general-meeting-of-xvivo-perfusion-is-moved-to-a-new-address-and,c3061999cision3602107Wed, 18 Mar 2020 07:30:00 GMTTHE COVID-19 EFFECT ON XVIVO PERFUSIONhttps://news.cision.com/xvivo-perfusion/r/the-covid-19-effect-on-xvivo-perfusion,c3062106cision3602026Wed, 18 Mar 2020 06:30:00 GMTAnnual Report 2019https://news.cision.com/xvivo-perfusion/r/annual-report-2019,c3054873cision3594448Mon, 09 Mar 2020 08:00:00 GMTNotice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)https://news.cision.com/xvivo-perfusion/r/notice-to-attend-the-annual-general-meeting-of-xvivo-perfusion-ab--publ-,c3045026cision3581066Mon, 24 Feb 2020 22:45:00 GMTA historic year ended with a quarter of sales recordshttps://news.cision.com/xvivo-perfusion/r/a-historic-year-ended-with-a-quarter-of-sales-records,c3022163cision3552283Thu, 30 Jan 2020 06:30:00 GMTConference call on Report on Operationshttps://news.cision.com/xvivo-perfusion/r/conference-call-on-report-on-operations,c3015958cision3546944Fri, 24 Jan 2020 07:00:00 GMTXVIVO Perfusion granted Breakthrough Device Designation from the FDA for the XVIVO Heart Preservation Systemhttps://news.cision.com/xvivo-perfusion/r/xvivo-perfusion-granted-breakthrough-device-designation-from-the-fda-for-the-xvivo-heart-preservatio,c2991871cision3517778Mon, 16 Dec 2019 10:00:00 GMTThird XPS™ sold in Australiahttps://news.cision.com/xvivo-perfusion/r/third-xps--sold-in-australia,c2947819cision3463774Tue, 29 Oct 2019 12:00:00 GMTGood growth and new important XPS clinicshttps://news.cision.com/xvivo-perfusion/r/good-growth-and-new-important-xps-clinics,c2939767cision3454169Thu, 24 Oct 2019 05:30:00 GMTXVIVO opens a subsidiary in Australiahttps://news.cision.com/xvivo-perfusion/r/xvivo-opens-a-subsidiary-in-australia,c2939545cision3453738Wed, 23 Oct 2019 14:00:00 GMTXVIVO Perfusion AB (publ) issue of warrants of series 2019/2021 fully subscribedhttps://news.cision.com/xvivo-perfusion/r/xvivo-perfusion-ab--publ--issue-of-warrants-of-series-2019-2021-fully-subscribed,c2939260cision3453425Wed, 23 Oct 2019 11:00:00 GMTConference call on Interim Reporthttps://news.cision.com/xvivo-perfusion/r/conference-call-on-interim-report,c2937191cision3450755Mon, 21 Oct 2019 11:30:00 GMT